Increased sdLDL, along with elevated levels of TRL, LDL cholesterol, oxidized LDL, and apoB and low levels of HDL-chol constitute the ‘atherogenic dyslipidemia complex’, a feature of type 2 diabetes and the metabolic syndrome [61]. This evidence concerns the gene APOB and type 2 diabetes mellitus.